Xiao-Nan Hong
Overview
Explore the profile of Xiao-Nan Hong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
193
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhang Y, Chen M, Zhou X, Hong X
PLoS One
. 2013 Jul;
8(6):e66411.
PMID: 23840460
Background: Non-Hodgkin's lymphoma (NHL) has been widely reported to be associated with autoimmune and pro-inflammatory response, and genetic polymorphisms of candidate genes involved in autoimmune and pro-inflammatory response may influence...
12.
Zhang Y, Wang M, He J, Wang J, Yang Y, Jin L, et al.
PLoS One
. 2012 Jun;
7(5):e37846.
PMID: 22666399
Background: Non-Hodgkin's lymphoma (NHL) has been reported to be associated with autoimmune and pro-inflammatory response, and genetic polymorphisms of candidate genes involved in autoimmune and pro-inflammatory response may influence the...
13.
Cao B, Ji D, Zhou X, Zhao T, Guo Y, Wang Z, et al.
Hematology
. 2011 Sep;
16(5):291-7.
PMID: 21902893
The objective of this study was to analyze the clinical behavior and treatment policy of patients with primary testicular diffuse large B-cell lymphoma by retrospective analysis of 32 patients at...
14.
Liu X, Guo Y, Fan Y, Gu K, Cao J, Wu X, et al.
Cancer Chemother Pharmacol
. 2011 Jul;
69(2):387-95.
PMID: 21789688
Purpose: Nodal peripheral T-cell lymphomas (PTCLs) have particularly poor prognoses. Few data enabling establishment of an accepted standard treatment modality for PTCLs are available. We hypothesized that fludarabine-based regimens are...
15.
Zhang J, Wang M, Xu L, Gu S, Cao J, Hu X, et al.
Zhonghua Zhong Liu Za Zhi
. 2010 Dec;
32(8):614-8.
PMID: 21122416
Objective: To analyze the clinical features and prognostic factors of primary gastric diffuse large B-cell lymphoma (PG-DLBCL) and to evaluate the staging system and treatment modality of PG-DLBCL. Methods: The...
16.
Zhao X, Hong X, Cao J, Leaw S, Guo Y, Li Z, et al.
Med Oncol
. 2010 May;
28(4):1559-64.
PMID: 20509008
To analyze the clinical characteristics, results of treatment, and prognostic factors of patients diagnosed as primary ovarian non-Hodgkin's lymphoma (PONHL). Fourteen cases of PONHL treated in Fudan University Cancer Center...
17.
Chen Z, Zhou X, Zhang T, Hong X, Yin J, Hu X, et al.
Zhonghua Zhong Liu Za Zhi
. 2009 Jul;
31(3):183-8.
PMID: 19615255
Objective: To explore the feasibility of semi-nested PCR technique for detection of immunoglobulin heavy chain (IgH) clonal rearrangement in bone marrow of B-cell lymphoma patient and to further evaluate its...
18.
Zhu X, Hu X, Zhang W, Hong X, Guo Y, Yin J, et al.
Hepatogastroenterology
. 2009 Jul;
56(90):555-60.
PMID: 19579642
Background/aims: The aim of this study was to evaluate the efficacy and tolerability of combination chemotherapy with epirubicin, cisplatin, 5-fluorouracil (ECF regimen), and Chloroxoquinoline in patients with metastatic gastric cancer....
19.
Liu X, Hong X, Gu Y, Wang B, Luo Z, Cao J
Leuk Lymphoma
. 2008 Sep;
49(9):1778-83.
PMID: 18798110
Rituximab is widely used for CD20+ non-Hodgkin lymphoma (NHL). The use of rituximab has been uncommonly associated with pulmonary toxicity. We report here a single institution experience on the clinical...
20.
Guo H, Zhao X, Cao J, Hu X, Yin J, Hong X, et al.
Zhonghua Zhong Liu Za Zhi
. 2008 Sep;
30(3):200-2.
PMID: 18756936
Objective: To analyze the clinical characteristics and prognosis of primary non-Hodgkin's lymphoma of the breast (PNHLB). Methods: The characteristics, treatment methods and outcomes of 45 patients with PNHLB were retrospectively...